About Pharmaq
Pharmaq is a company based in Oslo (Norway) founded in 2004, and was acquired by Zoetis in November 2015. Fish vaccines, equipment, and diagnostic services for aquaculture are developed. The company has 213 employees. Pharmaq has completed 2 acquisitions, including Fish Vet Group and Nordland Set Vaks. Pharmaq offers products and services including Fish Vaccines and Vaccination Equipment. Its legal entity is PHARMAQ AS.
Company details
Pharmaq was founded in 2004 in Oslo, Norway, focusing on the aquaculture sector. Vaccines and therapeutics are developed and manufactured to address fish diseases. Vaccination machinery and equipment are produced to facilitate administration processes. Diagnostic services, along with research-informed advice, are offered to support fish health and welfare. These activities contribute to sustainable operations within the global aquaculture industry.
- Headquarters Oslo, Norway
- Employees 213
- Stage Acquired
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website pharmaq.no
- Social LinkedIn
- Acquired by Zoetis (Nov 2015)
- Legal Name Pharmaq As
- Annual Revenue$843.9 M (USD)4as on Dec 31, 2022
- Net Profit$220.79 M (USD)4as on Dec 31, 2022
- EBITDA$220.48 M (USD)4as on Dec 31, 2022
- InvestorsZoetis
& 5 more
- Employee Count213
- Investments & AcquisitionsFish Vet Group
& 1 more
- Acquired by
Products & Services of Pharmaq
Pharmaq offers a comprehensive portfolio of products and services, including Fish Vaccines and Vaccination Equipment.
Vaccines for fish are developed and supplied by PHARMAQ to prevent diseases and improve welfare in aquaculture settings
Vaccination tools and related services are offered by PHARMAQ to facilitate fish health management in commercial operations
Funding Insights of Pharmaq
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Pharmaq with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2008 | Seed | β | β |
6 investors in total: 6 institutional.
Investors in Pharmaq
Pharmaq has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Zoetis, Permira and Orkla.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in technology, consumer, healthcare, and service sectors. | 1985 | permira.com | London, United Kingdom | |
Kverva is focused on investments in the marine sector. | kverva.no | Trondheim, Norway | ||
Consulting services in agriculture, travel, and international investments are offered. | 2004 | innovasjonnorge.no | Oslo, Norway | |
Higher education and research for development are provided by Norad. | 1968 | norad.no | Oslo, Norway | |
Orkla is recognized as a leading industrial investment company. | 1654 | orkla.com | Oslo, Norway | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | zoetis.com | Brussels, Belgium |
Investor details for Pharmaq
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmaq
Pharmaq has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Fish Vet Group and Nordland Set Vaks.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Veterinary healthcare research services for fish are provided. | fishvetgroup.com | Sheffield, United Kingdom | 1995 | Jul 2020 | β’β’β’β’ | |
Machinery for fish vaccination is manufactured and supplied. | vaksinering.com | 1995 | Jan 2017 | β’β’β’β’ |
Complete acquisition details for Pharmaq
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Pharmaq
7 dated milestones of Pharmaq across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmaq is founded.
- Funding First funding round.
- Exit Acquired by Orkla.
- Exit Acquired by Permira.
- Exit Acquired by Zoetis.
- Acquisition Acquires Nordland Set Vaks.
- Acquisition Acquires Fish Vet Group.
Web traffic of Pharmaq
Websites that share an audience with Pharmaq (pharmaq.no).
Websites whose visitors overlap most with Pharmaq. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
med-pharmex.com | med-pharmex.com | 100% | #13,726,993 | β | |
apexlabs.com.au | apexlabs.com.au | 100% | β | ||
macleodpharma.com | macleodpharma.com | 100% | β | ||
dehteq.co.za | dehteq.co.za | 100% | β | ||
samu.co.kr | samu.co.kr | 100% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 14 similar websites and full traffic analytics for Pharmaq
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmaq
Pharmaq was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Pharmaq is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Pharmaq has 213 employees.
Annual revenue of Pharmaq is $843.9M as on Dec 31, 2022.
Pharmaq was founded in 2004 in Oslo, Norway, focusing on the aquaculture sector. Vaccines and therapeutics are developed and manufactured to address fish diseases. Vaccination machinery and equipment are produced to facilitate administration processes. Diagnostic services, along with research-informed advice, are offered to support fish health and welfare. These activities contribute to sustainable operations within the global aquaculture industry.
Pharmaq offers Fish Vaccines and Vaccination Equipment.
Pharmaq has made 2 acquisitions, including Fish Vet Group, and Nordland Set Vaks.
Pharmaq has 6 investors. Key investors include Zoetis, Permira, Orkla, Innovasjon Norge, and Norad.
Pharmaq operates through Pharmaq As.
Yes. Pharmaq was acquired by Zoetis in November 2015.
